Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 1,072

The DOI matches its Crossref record; 862 of the 862 references it cites were found in a registry or an index.

2025 ESC/EACTS Guidelines for the management of valvular heart disease

Open access
Praz, Fabien, Borger, Michael A, Lanz, Jonas, Marin-Cuartas, Mateo, Abreu, Ana, Adamo, Marianna, Ajmone Marsan, Nina, Barili, Fabio, Bonaros, Nikolaos, Cosyns, Bernard, De Paulis, Ruggero, Gamra, Habib, Jahangiri, Marjan, Jeppsson, Anders, Klautz, Robert J M, Mores, Benoit, Pérez-David, Esther, Pöss, Janine, Prendergast, Bernard D, Rocca, Bianca, Rossello, Xavier, Suzuki, Mikio, Thiele, Holger, Tribouilloy, Christophe Michel, Wojakowski, Wojtek, ESC/EACTS Scientific Document Group, Vahanian, Alec, Mestres, Carlos-A, Abid, Leila, Aktaa, Suleman, Akowuah, Enoch F, Arbelo, Elena, Asselbergs, Folkert W, Barbato, Emanuele, Boriani, Giuseppe, Brida, Margarita, Buccheri, Sergio, Byrne, Robert A, Chioncel, Ovidiu, Conradi, Lenard, De Bonis, Michele, Delgado, Victoria, Franzone, Anna, Haugaa, Kristina Hermann, Heidecker, Bettina, Ibanez, Borja, Iung, Bernard, James, Stefan, Køber, Lars, Koskinas, Konstantinos C, Landmesser, Ulf, Lip, Gregory Y H, McEvoy, John William, Meltzer, Gil, Messika-Zeitoun, David, Mihaylova, Borislava, Mindham, Richard, Moelgaard, Inge, Nielsen, Jens Cosedis, Owens, Gareth, Pasquet, Agnes A, Pilgrim, Thomas, Prescott, Eva, Quintana, Eduard, Rudolph, Volker, Sadaba, Rafael, Sannino, Anna, Tanner, Felix C, Urena, Marina, Vaartjes, Ilonca, Vrints, Christiaan, Wahba, Alexander, Walther, Thomas, Witkowski, Adam, Zeppenfeld, Katja, Shuka, Naltin, Kichou, Brahim, Chilingaryan, Aram L, Bartko, Philipp Emanuel, Samadov, Fuad, Van de Heyning, Caroline M, Kusljugic, Zumreta, Kinova, Elena, Bulum, Josko, Eftychiou, Christos, Linkova, Hana, Fosbøl, Emil, Bahaa, Hesham, Truusalu, Jaagup, Piuhola, Jarkko, Donal, Erwan, Petriashvili, Shalva, Rudolph, Tanja Katharina, Drakopoulou, Maria, Kertész, Attila, Guðmundsson, Hjalti, Cole, Ben, Carasso, Shemy, Navazio, Alessandro, Sugralimova, Madina, Bajraktari, Gani, Kerimkulova, Alina, Elgdhafi, Elham Omran, Glaveckaite, Sigita, Lebrun, Frederic, Demarco, Daniela Cassar, Lisii, Dorin Mihail, Streukens, Sebastian, Antova, Emilija, Dalen, Håvard, Kukulski, Tomasz, Gavina, Cristina, Popescu, Bogdan A, Bini, Roberto, Ivanov, Igor, Hudec, Martin, Bunc, Matjaž, Bermejo, Thomas Javier, Meurling, Carl Johan Cronstedt, Jeger, Raban, Abid, Leila, Degertekin, Muzaffer M, Nesukay, Elena G, Garbi, Madalina, Mullabayeva, Guzal, Grabenwoeger, Martin, Eynden, Frederic Vanden, Vojacek, Jan, Vincentelli, André, Falk, Volkmar, Dedeilias, Panagiotis, Parolari, Alessandro, Braun, Jerry, Nikolic, Aleksandar, Ellensen, Vegard S, Sousa-Uva, Miguel, Micovic, Slobodan, Legarra, Juan J, Ferrari, Enrico, Moorjani, Narain·2025·European Heart Journal
DOI 10.1093/eurheartj/ehaf194
Open this paper in CoChat — free account

Abstract

The European Society of Cardiology (ESC)/European Association for Cardio-Thoracic Surgery (EACTS) Guidelines represent the views of the ESC and the EACTS and were produced after careful consideration of the scientific and medical knowledge and the evidence available at the time of their publication.The ESC and the EACTS are not responsible in the event of any contradiction, discrepancy and/or ambiguity between the ESC/EACTS Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies.Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account when exercising their clinical judgement, as well as in the determination and the implementation of preventive, diagnostic or therapeutic medical strategies; however, the ESC/EACTS Guidelines do not override, in any way whatsoever, the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient's health condition and in consultation with that patient and, where appropriate and/or necessary, the patient's caregiver.Nor do the ESC/EACTS Guidelines exempt health professionals from taking into full and careful consideration the relevant official updated recommendations or guidelines issued by the competent public health authorities, in order to manage each patient's case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations.It is also the health professional's responsibility to verify the applicable rules and regulations relating to drugs and medical devices prior to making any clinical decision and to check whether a more recent version of this document exists.The ESC and the EACTS warn readers that the technical language may be misinterpreted and decline any responsibility in this respect.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehaf194

Cites

862 of 862 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 862 references

Research works printed but not linked: 150

  1. Forrest, 2023, 4-Year outcomes of patients with aortic stenosis in the Evolut low risk trial, J Am Coll Cardiol, 82, 2163, 10.1016/j.jacc.2023.09.813 · doi:10.1016/j.jacc.2023.09.813
  2. Leonardi, 2021, Composition, structure, and function of heart teams: a joint position paper of the ACVC, EAPCI, EACTS, and EACTA focused on the management of patients with complex coronary artery disease requiring myocardial revascularization, Eur Heart J Acute Cardiovasc Care, 10, 83, 10.1093/ehjacc/zuaa013 · doi:10.1093/ehjacc/zuaa013
  3. Wild, 2025, Transcatheter valve repair for tricuspid regurgitation: 1-year results from a large European real-world registry, J Am Coll Cardiol, 85, 220, 10.1016/j.jacc.2024.10.068 · doi:10.1016/j.jacc.2024.10.068
  4. Compagnone, 2019, Surgical risk scores applied to transcatheter aortic valve implantation: friends or foes? Short-term and long-term outcomes from a single-center registry, J Invasive Cardiol, 31, E282, 10.25270/jic/19.3110.E282 · doi:10.25270/jic/19.3110.e282
  5. Shah, 2022, Prediction of death or HF hospitalization in patients with severe FMR: the COAPT risk score, JACC Cardiovasc Interv, 15, 1893, 10.1016/j.jcin.2022.08.005 · doi:10.1016/j.jcin.2022.08.005
  6. Adamo, 2023, Prediction of mortality and heart failure hospitalisations in patients undergoing M-TEER: external validation of the COAPT risk score, EuroIntervention, 18, 1408, 10.4244/EIJ-D-22-00992 · doi:10.4244/eij-d-22-00992
  7. Dreyfus, 2023, Predictive value of the TRI-SCORE for in-hospital mortality after redo isolated tricuspid valve surgery, Heart, 109, 951, 10.1136/heartjnl-2022-322167 · doi:10.1136/heartjnl-2022-322167
  8. Pagnesi, 2025, Malnutrition and outcomes in patients with tricuspid regurgitation undergoing transcatheter tricuspid valve repair, Eur J Heart Fail, 10.1002/ejhf.3623 · doi:10.1002/ejhf.3623
  9. Lund, 1996, Mortality and worsening of prognostic profile during waiting time for valve replacement in aortic stenosis, Thorac Cardiovasc Surg, 44, 289, 10.1055/s-2007-1012039 · doi:10.1055/s-2007-1012039
  10. Lancellotti, 2013, Stress echocardiography in regurgitant valve disease, Circ Cardiovasc Imaging, 6, 840, 10.1161/CIRCIMAGING.113.000474 · doi:10.1161/circimaging.113.000474
  11. Ardehali, 1995, Coronary blood flow reserve in acute aortic regurgitation, J Am Coll Cardiol, 25, 1387, 10.1016/0735-1097(95)00018-Y · doi:10.1016/0735-1097(95)00018-y
  12. Akasaka, 1998, Restricted coronary flow reserve in patients with mitral regurgitation improves after mitral reconstructive surgery, J Am Coll Cardiol, 32, 1923, 10.1016/S0735-1097(98)00490-2 · doi:10.1016/s0735-1097(98)00490-2
  13. Malebranche, 2022, Diagnostic performance of quantitative coronary artery disease assessment using computed tomography in patients with aortic stenosis undergoing transcatheter aortic-valve implantation, BMC Cardiovasc Disord, 22, 178, 10.1186/s12872-022-02623-8 · doi:10.1186/s12872-022-02623-8
  14. Okuno, 2022, Long-term risk of unplanned percutaneous coronary intervention after transcatheter aortic valve replacement, EuroIntervention, 18, 797, 10.4244/eij-d-22-00342 · doi:10.4244/eij-d-22-00342
  15. Ogami, 2023, Acute coronary syndrome after transcatheter aortic valve implantation (results from over 40,000 patients), Am J Cardiol, 193, 126, 10.1016/j.amjcard.2023.02.003 · doi:10.1016/j.amjcard.2023.02.003
  16. Costa, 2024, Coronary cannulation following TAVR using self-expanding devices with commissural alignment: the RE-ACCESS 2 study, JACC Cardiovasc Interv, 17, 727, 10.1016/j.jcin.2023.12.015 · doi:10.1016/j.jcin.2023.12.015
  17. Campwala, 2005, Factors affecting regression of mitral regurgitation following isolated coronary artery bypass surgery, Eur J Cardiothorac Surg, 28, 783, 10.1016/j.ejcts.2005.10.010 · doi:10.1016/j.ejcts.2005.10.010
  18. Yousefzai, 2014, Outcomes of patients with ischemic mitral regurgitation undergoing percutaneous coronary intervention, Am J Cardiol, 114, 1011, 10.1016/j.amjcard.2014.07.012 · doi:10.1016/j.amjcard.2014.07.012
  19. Naser, 2022, Unfavorable tricuspid annulus dynamics: a novel concept to explain development of tricuspid regurgitation in atrial fibrillation, J Am Soc Echocardiogr, 35, 664, 10.1016/j.echo.2022.02.009 · doi:10.1016/j.echo.2022.02.009
  20. Gujral, 2016, Radiation-induced valvular heart disease, Heart, 102, 269, 10.1136/heartjnl-2015-308765 · doi:10.1136/heartjnl-2015-308765
  21. Zafar, 2020, Outcomes after transcatheter aortic valve replacement in cancer survivors with prior chest radiation therapy: a systematic review and meta-analysis, Cardiooncology, 6, 8, 10.1186/s40959-020-00062-y · doi:10.1186/s40959-020-00062-y
  22. Ullah, 2023, Trends and outcomes of TAVI and SAVR in cancer and noncancer patients, JACC Adv, 2, 100167, 10.1016/j.jacadv.2022.100167 · doi:10.1016/j.jacadv.2022.100167
  23. Moreno, 1994, The role of percutaneous aortic balloon valvuloplasty in patients with cardiogenic shock and critical aortic stenosis, J Am Coll Cardiol, 23, 1071, 10.1016/0735-1097(94)90592-4 · doi:10.1016/0735-1097(94)90592-4
  24. Llah, 2023, TAVR vs balloon aortic valvotomy for severe aortic stenosis and cardiogenic shock: an insight from the national inpatient sample database, Cardiovasc Revasc Med, 55, 1, 10.1016/j.carrev.2023.05.006 · doi:10.1016/j.carrev.2023.05.006
  25. deCampos, 2020, Global longitudinal strain in chronic asymptomatic aortic regurgitation: systematic review, Echo Res Pract, 7, 39, 10.1530/erp-20-0024 · doi:10.1530/erp-20-0024
  26. Malahfji, 2023, Influence of cardiac remodeling on clinical outcomes in patients with aortic regurgitation, J Am Coll Cardiol, 81, 1885, 10.1016/j.jacc.2023.03.001 · doi:10.1016/j.jacc.2023.03.001
  27. Chauvette, 2022, Outcomes of valve-sparing surgery in heritable aortic disorders: results from the AVIATOR registry, Eur J Cardiothorac Surg, 62, 10.1093/ejcts/ezac366 · doi:10.1093/ejcts/ezac366
  28. Bohbot, 2021, Survival and management of patients with discordant high-gradient aortic stenosis: a propensity-matched study, JACC Cardiovasc Imaging, 14, 1672, 10.1016/j.jcmg.2021.02.010 · doi:10.1016/j.jcmg.2021.02.010
  29. Maznyczka, 2024, Fibrotic vs calcific aortic stenosis: characteristics and outcomes in patients undergoing transcatheter aortic valve replacement, JACC Cardiovasc Interv, 17, 2969, 10.1016/j.jcin.2024.09.041 · doi:10.1016/j.jcin.2024.09.041
  30. Thellier, 2023, Additive prognostic value of left ventricular dispersion and deformation in patients with severe aortic stenosis, JACC Cardiovasc Imaging, 17, 235, 10.1016/j.jcmg.2023.09.010 · doi:10.1016/j.jcmg.2023.09.010
  31. Gleitman, 2020, Similar procedural success of transcutaneous aortic valve replacement with prosthesis valve sizing by either three-dimensional transesophageal echocardiography modeling or computed tomography, J Am Soc Echocardiogr, 33, 1149, 10.1016/j.echo.2020.05.026 · doi:10.1016/j.echo.2020.05.026
  32. Notenboom, 2023, Long-term clinical and echocardiographic outcomes following the Ross procedure: a post hoc analysis of a randomized clinical trial, JAMA Cardiology, 9, 6, 10.1001/jamacardio.2023.4090 · doi:10.1001/jamacardio.2023.4090
  33. Sharma, 2022, National trends in TAVR and SAVR for patients with severe isolated aortic stenosis, J Am Coll Cardiol, 80, 2054, 10.1016/j.jacc.2022.08.787 · doi:10.1016/j.jacc.2022.08.787
  34. Faroux, 2020, Clinical impact of conduction disturbances in transcatheter aortic valve replacement recipients: a systematic review and meta-analysis, Eur Heart J, 41, 2771, 10.1093/eurheartj/ehz924 · doi:10.1093/eurheartj/ehz924
  35. Tam, 2021, The cost-effectiveness of transcatheter aortic valve replacement in low surgical risk patients with severe aortic stenosis, Eur Heart J Qual Care Clin Outcomes, 7, 556, 10.1093/ehjqcco/qcaa058 · doi:10.1093/ehjqcco/qcaa058
  36. Paparella, 2020, Full sternotomy and minimal access approaches for surgical aortic valve replacement: a multicentre propensity-matched study, Eur J Cardiothorac Surg, 57, 709, 10.1093/ejcts/ezz286 · doi:10.1093/ejcts/ezz286
  37. Bowdish, 2024, Cardiac surgery after transcatheter aortic valve replacement: trends and outcomes, Ann Thorac Surg, 118, 155, 10.1016/j.athoracsur.2024.03.024 · doi:10.1016/j.athoracsur.2024.03.024
  38. Ternacle, 2021, Prosthesis-patient mismatch after aortic valve replacement in the PARTNER 2 trial and registry, JACC Cardiovasc Interv, 14, 1466, 10.1016/j.jcin.2021.03.069 · doi:10.1016/j.jcin.2021.03.069
  39. Akodad, 2022, Balloon-expandable valve for treatment of Evolut valve failure, JACC Cardiovasc Interv, 15, 368, 10.1016/j.jcin.2021.12.021 · doi:10.1016/j.jcin.2021.12.021
  40. Akodad, 2021, Leaflet and neoskirt height in transcatheter heart valves, JACC Cardiovasc Interv, 14, 2298, 10.1016/j.jcin.2021.07.034 · doi:10.1016/j.jcin.2021.07.034
  41. Tang, 2023, Feasibility of coronary access following redo-TAVR for Evolut failure: a computed tomography simulation study, Circ Cardiovasc Interv, 16, e013238, 10.1161/CIRCINTERVENTIONS.123.013238 · doi:10.1161/circinterventions.123.013238
  42. Fukui, 2023, Feasibility of redo-transcatheter aortic valve replacement in Sapien valves based on in vivo computed tomography assessment, Circ Cardiovasc Interv, 16, e013497, 10.1161/CIRCINTERVENTIONS.123.013497 · doi:10.1161/circinterventions.123.013497
  43. Khan, 2021, Preventing coronary obstruction during transcatheter aortic valve replacement: results from the multicenter international BASILICA registry, JACC Cardiovasc Interv, 14, 941, 10.1016/j.jcin.2021.02.035 · doi:10.1016/j.jcin.2021.02.035
  44. Tang, 2020, Alignment of transcatheter aortic-valve neo-commissures (ALIGN TAVR): impact on final valve orientation and coronary artery overlap, JACC Cardiovasc Interv, 13, 1030, 10.1016/j.jcin.2020.02.005 · doi:10.1016/j.jcin.2020.02.005
  45. Mosleh, 2021, Benefit of transcatheter aortic valve replacement in patients with paradoxical low-flow low-gradient versus high-gradient aortic stenosis and preserved left ventricular function, Circ Cardiovasc Interv, 14, e010042, 10.1161/circinterventions.120.010042 · doi:10.1161/circinterventions.120.010042
  46. Allen, 2019, Transcarotid versus transapical and transaortic access for transcatheter aortic valve replacement, Ann Thorac Surg, 108, 715, 10.1016/j.athoracsur.2019.02.007 · doi:10.1016/j.athoracsur.2019.02.007
  47. Overtchouk, 2019, Transcarotid approach for transcatheter aortic valve replacement with the Sapien 3 prosthesis, JACC Cardiovasc Interv, 12, 413, 10.1016/j.jcin.2018.11.014 · doi:10.1016/j.jcin.2018.11.014
  48. Allen, 2023, Transcarotid versus transaxillary access for transcatheter aortic valve replacement with a self-expanding valve: a propensity-matched analysis, JTCVS Tech, 21, 45, 10.1016/j.xjtc.2023.07.019 · doi:10.1016/j.xjtc.2023.07.019
  49. Abraham, 2023, Meta-analysis on transcarotid versus transfemoral and other alternate accesses for transcatheter aortic valve implantation, Am J Cardiol, 192, 196, 10.1016/j.amjcard.2023.01.023 · doi:10.1016/j.amjcard.2023.01.023
  50. Waksman, 2020, Transcatheter aortic valve replacement in low-risk patients with symptomatic severe bicuspid aortic valve stenosis, JACC Cardiovasc Interv, 13, 1019, 10.1016/j.jcin.2020.02.008 · doi:10.1016/j.jcin.2020.02.008
  51. Oz, 2023, Cardiac rehabilitation after TAVI—a systematic review and meta-analysis, Curr Probl Cardiol, 48, 101531, 10.1016/j.cpcardiol.2022.101531 · doi:10.1016/j.cpcardiol.2022.101531
  52. Del Rio-Pertuz, 2023, Right heart catheterization in clinical practice: a review of basic physiology and important issues relevant to interpretation, Am J Cardiovasc Dis, 13, 122
  53. Feuchtner, 2010, Cardiac CT angiography for the diagnosis of mitral valve prolapse: comparison with echocardiography, Radiology, 254, 374, 10.1148/radiol.2541090393 · doi:10.1148/radiol.2541090393
  54. Tarzia, 2023, Multi-modality imaging for pre-procedural planning of transcatheter mitral valve interventions, Eur Heart J Suppl, 25, C205, 10.1093/eurheartjsupp/suad021 · doi:10.1093/eurheartjsupp/suad021
  55. Brescia, 2022, Rheumatic mitral valve repair or replacement in the valve-in-valve era, J Thorac Cardiovasc Surg, 163, 591, 10.1016/j.jtcvs.2020.04.118 · doi:10.1016/j.jtcvs.2020.04.118
  56. Chen, 2022, Mitral valve repair versus replacement in patients with rheumatic heart disease, J Thorac Cardiovasc Surg, 164, 57, 10.1016/j.jtcvs.2020.07.117 · doi:10.1016/j.jtcvs.2020.07.117
  57. Yun, 2002, Randomized trial comparing partial versus complete chordal-sparing mitral valve replacement: effects on left ventricular volume and function, J Thorac Cardiovasc Surg, 123, 707, 10.1067/mtc.2002.121048 · doi:10.1067/mtc.2002.121048
  58. von Bardeleben, 2023, 1-Year outcomes with fourth-generation mitral valve transcatheter edge-to-edge repair from the EXPAND G4 study, JACC Cardiovasc Interv, 16, 2600, 10.1016/j.jcin.2023.09.029 · doi:10.1016/j.jcin.2023.09.029
  59. Wild, 2022, Transapical mitral valve implantation for treatment of symptomatic mitral valve disease: a real-world multicentre experience, Eur J Heart Fail, 24, 899, 10.1002/ejhf.2434 · doi:10.1002/ejhf.2434
  60. Weiner, 2019, Impact of mitral valve repair on the Pickelhaube sign, Eur Heart J, 40, 2267, 10.1093/eurheartj/ehy458 · doi:10.1093/eurheartj/ehy458
  61. Bonaros, 2022, Predictors of safety and success in minimally invasive surgery for degenerative mitral disease, Eur J Cardiothorac Surg, 61, 637, 10.1093/ejcts/ezab438 · doi:10.1093/ejcts/ezab438
  62. Berretta, 2023, Risk-related clinical outcomes after minimally invasive mitral valve surgery: insights from the Mini-Mitral International Registry, Eur J Cardiothorac Surg, 63, ezad090, 10.1093/ejcts/ezad090 · doi:10.1093/ejcts/ezad090
  63. Pfannmueller, 2021, Loop neochord versus leaflet resection techniques for minimally invasive mitral valve repair: long-term results, Eur J Cardiothorac Surg, 59, 180, 10.1093/ejcts/ezaa255 · doi:10.1093/ejcts/ezaa255
  64. Olsthoorn, 2022, Effect of minimally invasive mitral valve surgery compared to sternotomy on short- and long-term outcomes: a retrospective multicentre interventional cohort study based on Netherlands Heart Registration, Eur J Cardiothorac Surg, 61, 1099, 10.1093/ejcts/ezab507 · doi:10.1093/ejcts/ezab507
  65. Speziale, 2011, Results of mitral valve repair for Barlow disease (bileaflet prolapse) via right minithoracotomy versus conventional median sternotomy: a randomized trial, J Thorac Cardiovasc Surg, 142, 77, 10.1016/j.jtcvs.2010.08.033 · doi:10.1016/j.jtcvs.2010.08.033
  66. Bartkowiak, 2022, Electrosurgical laceration and stabilization of MitraClip followed by valve implantation for iatrogenic mitral stenosis, JACC Cardiovasc Interv, 15, 110, 10.1016/j.jcin.2021.10.011 · doi:10.1016/j.jcin.2021.10.011
  67. Lisko, 2020, Electrosurgical detachment of MitraClips from the anterior mitral leaflet prior to transcatheter mitral valve implantation, JACC Cardiovasc Interv, 13, 2361, 10.1016/j.jcin.2020.06.047 · doi:10.1016/j.jcin.2020.06.047
  68. Okamoto, 2021, Prognostic comparison of atrial and ventricular functional mitral regurgitation, Open Heart, 8, e001574, 10.1136/openhrt-2021-001574 · doi:10.1136/openhrt-2021-001574
  69. Doldi, 2022, Transcatheter mitral valve repair in patients with atrial functional mitral regurgitation, JACC Cardiovasc Imaging, 15, 1843, 10.1016/j.jcmg.2022.05.009 · doi:10.1016/j.jcmg.2022.05.009
  70. von Stein, 2025, Atrial functional mitral regurgitation subtypes undergoing transcatheter edge-to-edge repair: suboptimal outcomes in atriogenic hamstringing, JACC Cardiovasc Imaging, 18, 16, 10.1016/j.jcmg.2024.06.019 · doi:10.1016/j.jcmg.2024.06.019
  71. Spinka, 2022, Guideline directed medical therapy and reduction of secondary mitral regurgitation, Eur Heart J Cardiovasc Imaging, 23, 755, 10.1093/ehjci/jeac068 · doi:10.1093/ehjci/jeac068
  72. Michalski, 2022, Relationship of mechanical dyssynchrony and LV remodeling with improvement of mitral regurgitation after CRT, JACC Cardiovasc Imaging, 15, 212, 10.1016/j.jcmg.2021.08.010 · doi:10.1016/j.jcmg.2021.08.010
  73. Goel, 2023, Transcatheter edge-to-edge repair in 5,000 patients with secondary mitral regurgitation: COAPT post-approval study, J Am Coll Cardiol, 82, 1281, 10.1016/j.jacc.2023.07.015 · doi:10.1016/j.jacc.2023.07.015
  74. Anker, 2021, Percutaneous mitral valve annuloplasty in patients with secondary mitral regurgitation and severe left ventricular enlargement, JACC Heart Fail, 9, 453, 10.1016/j.jchf.2021.03.002 · doi:10.1016/j.jchf.2021.03.002
  75. von Stumm, 2021, Predicting clinical outcome by indexed mitral valve tenting in functional mitral valve regurgitation, Open Heart, 8, e001483, 10.1136/openhrt-2020-001483 · doi:10.1136/openhrt-2020-001483
  76. Girdauskas, 2022, Subannular repair for functional mitral regurgitation with reduced systolic ventricle function: rationale and design of REFORM-MR registry, J Cardiothorac Surg, 17, 343, 10.1186/s13019-022-02045-9 · doi:10.1186/s13019-022-02045-9
  77. Pausch, 2021, Subannular repair for functional mitral regurgitation type IIIb in patients with ischaemic versus dilated cardiomyopathy, Eur J Cardiothorac Surg, 60, 122, 10.1093/ejcts/ezab048 · doi:10.1093/ejcts/ezab048
  78. Altarabsheh, 2017, Meta-analysis of usefulness of concomitant mitral valve repair or replacement for moderate ischemic mitral regurgitation with coronary artery bypass grafting, Am J Cardiol, 119, 734, 10.1016/j.amjcard.2016.11.024 · doi:10.1016/j.amjcard.2016.11.024
  79. Wagner, 2024, Surgical strategy and outcomes for atrial functional mitral regurgitation: all functional mitral regurgitation is not the same!, J Thorac Cardiovasc Surg, 167, 647, 10.1016/j.jtcvs.2022.02.056 · doi:10.1016/j.jtcvs.2022.02.056
  80. Balogh, 2020, Mitral valve repair of atrial functional mitral regurgitation in heart failure with preserved ejection fraction, J Clin Med, 9, 3432, 10.3390/jcm9113432 · doi:10.3390/jcm9113432
  81. Benito-González, 2021, Clinical and echocardiographic outcomes of transcatheter mitral valve repair in atrial functional mitral regurgitation, Int J Cardiol, 345, 29, 10.1016/j.ijcard.2021.09.056 · doi:10.1016/j.ijcard.2021.09.056
  82. Rudolph, 2024, Transcatheter repair versus surgery for atrial versus ventricular functional mitral regurgitation: a post hoc analysis of the MATTERHORN trial, Circulation, 151, 418, 10.1161/circulationaha.124.072648 · doi:10.1161/circulationaha.124.072648
  83. Tanaka, 2024, Outcomes of transcatheter edge-to-edge repair for atrial functional mitral regurgitation, EuroIntervention, 20, e250, 10.4244/eij-d-23-00819 · doi:10.4244/eij-d-23-00819
  84. Brochet, 2011, Early hemodynamic changes versus peak values: what is more useful to predict occurrence of dyspnea during stress echocardiography in patients with asymptomatic mitral stenosis?, J Am Soc Echocardiogr, 24, 392, 10.1016/j.echo.2011.01.006 · doi:10.1016/j.echo.2011.01.006
  85. Sharma, 2016, Evaluation of early direct current cardioversion for maintenance of sinus rhythm in rheumatic atrial fibrillation following successful balloon mitral valvotomy, Indian Heart J, 68, 486, 10.1016/j.ihj.2015.11.013 · doi:10.1016/j.ihj.2015.11.013
  86. Ambari, 2019, Survival analysis of patients with rheumatic MS after PBMV compared with MVS in a low-to-middle-income country, Neth Heart J, 27, 559, 10.1007/s12471-019-01315-x · doi:10.1007/s12471-019-01315-x
  87. Soesanto, 2022, Clinical and hemodynamic factors associated with low gradient severe rheumatic mitral stenosis, Int J Angiol, 32, 43, 10.1055/s-0042-1751231 · doi:10.1055/s-0042-1751231
  88. Guerrero, 2023, Diagnosis, classification, and management strategies for mitral annular calcification, JACC Cardiovasc Interv, 16, 2195, 10.1016/j.jcin.2023.06.044 · doi:10.1016/j.jcin.2023.06.044
  89. Uchimuro, 2016, Mitral valve surgery in patients with severe mitral annular calcification, Ann Thorac Surg, 101, 889, 10.1016/j.athoracsur.2015.08.071 · doi:10.1016/j.athoracsur.2015.08.071
  90. Fukui, 2022, Clinical outcomes of mitral valve disease with mitral annular calcification, Am J Cardiol, 174, 107, 10.1016/j.amjcard.2022.03.041 · doi:10.1016/j.amjcard.2022.03.041
  91. Brener, 2024, Early outcomes following transatrial transcatheter mitral valve replacement in patients with severe mitral annular calcification, J Thorac Cardiovasc Surg, 167, 1263, 10.1016/j.jtcvs.2022.07.038 · doi:10.1016/j.jtcvs.2022.07.038
  92. Guerrero, 2023, 5-Year prospective evaluation of mitral valve-in-valve, valve-in-ring, and valve-in-MAC outcomes: MITRAL trial final results, JACC Cardiovasc Interv, 16, 2211, 10.1016/j.jcin.2023.06.041 · doi:10.1016/j.jcin.2023.06.041
  93. Galloo, 2023, Prognostic implications of atrial vs. ventricular functional tricuspid regurgitation, Eur Heart J Cardiovasc Imaging, 24, 733, 10.1093/ehjci/jead016 · doi:10.1093/ehjci/jead016
  94. Fortuni, 2021, Prognostic implications of a novel algorithm to grade secondary tricuspid regurgitation, JACC Cardiovasc Imaging, 14, 1085, 10.1016/j.jcmg.2020.12.011 · doi:10.1016/j.jcmg.2020.12.011
  95. Addetia, 2023, Normal values of three-dimensional right ventricular size and function measurements: results of the World Alliance Societies of Echocardiography study, J Am Soc Echocardiogr, 36, 858, 10.1016/j.echo.2023.04.011 · doi:10.1016/j.echo.2023.04.011
  96. Brener, 2022, Right ventricular-pulmonary arterial coupling and afterload reserve in patients undergoing transcatheter tricuspid valve repair, J Am Coll Cardiol, 79, 448, 10.1016/j.jacc.2021.11.031 · doi:10.1016/j.jacc.2021.11.031
  97. Stolz, 2023, Invasive right ventricular to pulmonary artery coupling in patients undergoing transcatheter edge-to-edge tricuspid valve repair, JACC Cardiovasc Imaging, 16, 564, 10.1016/j.jcmg.2022.10.004 · doi:10.1016/j.jcmg.2022.10.004
  98. Anguita-Gámez, 2023, Validation of the TRI-SCORE in patients undergoing surgery for isolated tricuspid regurgitation, Heart, 109, 1401, 10.1136/heartjnl-2022-322067 · doi:10.1136/heartjnl-2022-322067
  99. Park, 2021, Determinants of clinical outcomes of surgery for isolated severe tricuspid regurgitation, Heart, 107, 403, 10.1136/heartjnl-2020-317715 · doi:10.1136/heartjnl-2020-317715
  100. Dreyfus, 2021, Outcome of consistent guideline-based tricuspid management in patients undergoing degenerative mitral regurgitation correction, JTCVS Open, 7, 125, 10.1016/j.xjon.2021.07.010 · doi:10.1016/j.xjon.2021.07.010
  101. Pettinari, 2019, Mid-term results of a randomized trial of tricuspid annuloplasty for less-than-severe functional tricuspid regurgitation at the time of mitral valve surgery, Eur J Cardiothorac Surg, 55, 851, 10.1093/ejcts/ezy378 · doi:10.1093/ejcts/ezy378
  102. Ailawadi, 2022, Pacemaker implantation associated with tricuspid repair in the setting of mitral valve surgery: insights from a Cardiothoracic Surgical Trials Network randomized trial, J Thorac Cardiovasc Surg, 167, 2104, 10.1016/j.jtcvs.2022.11.031 · doi:10.1016/j.jtcvs.2022.11.031
  103. von Bardeleben, 2023, Two-year outcomes for tricuspid repair with a transcatheter edge-to-edge valve repair from the transatlantic TRILUMINATE trial, Circ Cardiovasc Interv, 16, e012888, 10.1161/CIRCINTERVENTIONS.122.012888 · doi:10.1161/circinterventions.122.012888
  104. Lurz, 2023, Short-term outcomes of tricuspid edge-to-edge repair in clinical practice, J Am Coll Cardiol, 82, 281, 10.1016/j.jacc.2023.05.008 · doi:10.1016/j.jacc.2023.05.008
  105. Chen, 2021, Transcatheter valve implantation for degenerated tricuspid bioprosthesis and failed tricuspid ring, Ann Cardiothorac Surg, 10, 651, 10.21037/acs-2021-tviv-11 · doi:10.21037/acs-2021-tviv-11
  106. Abdelbar, 2021, Minimally invasive tricuspid valve surgery, J Thorac Dis, 13, 1982, 10.21037/jtd-20-1331 · doi:10.21037/jtd-20-1331
  107. Donal, 2024, Characterization of tricuspid valve anatomy and coaptation gap in subjects receiving tricuspid transcatheter edge-to-edge repair: observations from the bRIGHT TriClip study, J Am Soc Echocardiogr, 37, 397, 10.1016/j.echo.2023.12.002 · doi:10.1016/j.echo.2023.12.002
  108. Sarralde, 2010, Repair of rheumatic tricuspid valve disease: predictors of very long-term mortality and reoperation, Ann Thorac Surg, 90, 503, 10.1016/j.athoracsur.2010.03.105 · doi:10.1016/j.athoracsur.2010.03.105
  109. Saran, 2019, Long-term outcomes of patients undergoing tricuspid valve surgery, Eur J Cardiothorac Surg, 56, 950, 10.1093/ejcts/ezz081 · doi:10.1093/ejcts/ezz081
  110. Pereyra, 2023, Percutaneous transcatheter pulmonary and tricuspid valve replacements in a patient with carcinoid heart disease, Eur Heart J Case Rep, 7, ytad511, 10.1093/ehjcr/ytad511 · doi:10.1093/ehjcr/ytad511
  111. Yunoki, 2006, Percutaneous transcatheter balloon valvuloplasty for bioprosthetic tricuspid valve stenosis, Circulation, 114, e558, 10.1161/CIRCULATIONAHA.106.618611 · doi:10.1161/circulationaha.106.618611
  112. de Marchi, 1999, Influence of left ventricular relaxation on the pressure half time of aortic regurgitation, Heart, 82, 607, 10.1136/hrt.82.5.607 · doi:10.1136/hrt.82.5.607
  113. Flachskampf, 1990, Aortic regurgitation shortens Doppler pressure half-time in mitral stenosis: clinical evidence, in vitro simulation and theoretic analysis, J Am Coll Cardiol, 16, 396, 10.1016/0735-1097(90)90592-d · doi:10.1016/0735-1097(90)90592-d
  114. Tribouilloy, 1994, Mitral to aortic velocity-time integral ratio: a non-geometric pulsed-Doppler regurgitant index in isolated pure mitral regurgitation, Eur Heart J, 15, 1335, 10.1093/oxfordjournals.eurheartj.a060390 · doi:10.1093/oxfordjournals.eurheartj.a060390
  115. Benfari, 2018, Concomitant mitral regurgitation and aortic stenosis: one step further to low-flow preserved ejection fraction aortic stenosis, Eur Heart J Cardiovasc Imaging, 19, 569, 10.1093/ehjci/jex172 · doi:10.1093/ehjci/jex172
  116. Furukawa, 2018, Mechanisms of changes in functional mitral regurgitation by preload alterations, J Cardiol, 71, 570, 10.1016/j.jjcc.2017.12.005 · doi:10.1016/j.jjcc.2017.12.005
  117. Bissessor, 2010, The role of natriuretic peptides in patients with chronic complex (mixed or multiple) heart valve disease, Congest Heart Fail, 16, 50, 10.1111/j.1751-7133.2009.00132.x · doi:10.1111/j.1751-7133.2009.00132.x
  118. Kavsur, 2021, Predictors and prognostic relevance of tricuspid alterations in patients undergoing transcatheter edge-to-edge mitral valve repair, EuroIntervention, 17, 827, 10.4244/eij-d-20-01094 · doi:10.4244/eij-d-20-01094
  119. Carpentier, 1996, Extensive calcification of the mitral valve anulus: pathology and surgical management, J Thorac Cardiovasc Surg, 111, 718, 10.1016/s0022-5223(96)70332-x · doi:10.1016/s0022-5223(96)70332-x
  120. Kiyose, 2019, Comparison of biological and mechanical prostheses for heart valve surgery: a systematic review of randomized controlled trials, Arq Bras Cardiol, 112, 292, 10.5935/abc.20180272 · doi:10.5935/abc.20180272
  121. Li, 2020, Comparison of different bridging anticoagulation therapies used after mechanical heart valve replacement in Chinese patients—a prospective cohort study, J Cardiothorac Surg, 15, 40, 10.1186/s13019-020-1084-7 · DOI
  122. Tao, 2020, A meta-analysis of bridging anticoagulation between low molecular weight heparin and heparin, Medicine (Baltimore), 99, e18729, 10.1097/MD.0000000000018729 · doi:10.1097/md.0000000000018729
  123. Meurin, 2006, Low-molecular-weight heparin as a bridging anticoagulant early after mechanical heart valve replacement, Circulation, 113, 564, 10.1161/circulationaha.105.575571 · doi:10.1161/circulationaha.105.575571
  124. Gunther, 2004, Low-dose oral vitamin K is safe and effective for outpatient management of patients with an INR>10, Thromb Res, 113, 205, 10.1016/j.thromres.2004.03.004 · doi:10.1016/j.thromres.2004.03.004
  125. Hood, 2023, INR and vitamin K-dependent factor levels after vitamin K antagonist reversal with 4F-PCC or plasma, Blood Adv, 7, 2206, 10.1182/bloodadvances.2022009015 · doi:10.1182/bloodadvances.2022009015
  126. Eichinger, 2016, Reversing vitamin K antagonists: making the old new again, Hematology Am Soc Hematol Educ Program, 2016, 605, 10.1182/asheducation-2016.1.605 · doi:10.1182/asheducation-2016.1.605
  127. Engelen, 2018, Antifibrinolytic therapy for preventing oral bleeding in people on anticoagulants undergoing minor oral surgery or dental extractions, Cochrane Database Syst Rev, 7, CD012293, 10.1002/14651858.CD012293.pub2 · doi:10.1002/14651858.cd012293.pub2
  128. Makuloluwa, 2019, Peri-operative management of ophthalmic patients on anti-thrombotic agents: a literature review, Eye (Lond), 33, 1044, 10.1038/s41433-019-0382-6 · doi:10.1038/s41433-019-0382-6
  129. Alkhalil, 2022, Aspirin versus dual antiplatelet therapy in patients undergoing trans-catheter aortic valve implantation, updated meta-analysis, Cardiovasc Drugs Ther, 36, 279, 10.1007/s10557-021-07146-6 · doi:10.1007/s10557-021-07146-6
  130. Meurin, 2008, Thromboembolic events early after mitral valve repair: incidence and predictive factors, Int J Cardiol, 126, 45, 10.1016/j.ijcard.2007.03.115 · doi:10.1016/j.ijcard.2007.03.115
  131. Trevis, 2022, Which antithrombotic strategy provides the best outcomes after mitral valve repair in patients who remain in sinus rhythm?, Interact Cardiovasc Thorac Surg, 35, ivac085, 10.1093/icvts/ivac085 · doi:10.1093/icvts/ivac085
  132. Kaneko, 2024, Transcatheter heart valve explantation for transcatheter aortic valve replacement failure: a Heart Valve Collaboratory expert consensus document on operative techniques, J Thorac Cardiovasc Surg, 169, 878, 10.1016/j.jtcvs.2024.04.025 · doi:10.1016/j.jtcvs.2024.04.025
  133. Eleid, 2017, Early outcomes of percutaneous transvenous transseptal transcatheter valve implantation in failed bioprosthetic mitral valves, ring annuloplasty, and severe mitral annular calcification, JACC Cardiovasc Interv, 10, 1932, 10.1016/j.jcin.2017.08.014 · doi:10.1016/j.jcin.2017.08.014
  134. Tomii, 2023, Long-term outcomes of measured and predicted prosthesis-patient mismatch following transcatheter aortic valve replacement, EuroIntervention, 19, 746, 10.4244/eij-d-23-00456 · doi:10.4244/eij-d-23-00456
  135. Vriesendorp, 2020, The fallacy of indexed effective orifice area charts to predict prosthesis–patient mismatch after prosthesis implantation, Eur Heart J Cardiovasc Imaging, 21, 1116, 10.1093/ehjci/jeaa044 · doi:10.1093/ehjci/jeaa044
  136. Blanke, 2020, Bioprosthetic aortic valve leaflet thickening in the Evolut Low Risk sub-study, J Am Coll Cardiol, 75, 2430, 10.1016/j.jacc.2020.03.022 · doi:10.1016/j.jacc.2020.03.022
  137. Makkar, 2020, Subclinical leaflet thrombosis in transcatheter and surgical bioprosthetic valves: PARTNER 3 cardiac computed tomography substudy, J Am Coll Cardiol, 75, 3003, 10.1016/j.jacc.2020.04.043 · doi:10.1016/j.jacc.2020.04.043
  138. Montalescot, 2022, Apixaban and valve thrombosis after transcatheter aortic valve replacement: the ATLANTIS-4D-CT randomized clinical trial substudy, JACC Cardiovasc Interv, 15, 1794, 10.1016/j.jcin.2022.07.014 · doi:10.1016/j.jcin.2022.07.014
  139. Ruile, 2017, Course of early subclinical leaflet thrombosis after transcatheter aortic valve implantation with or without oral anticoagulation, Clin Res Cardiol, 106, 85, 10.1007/s00392-016-1052-3 · doi:10.1007/s00392-016-1052-3
  140. Özkan, 2022, Thrombolysis or surgery in patients with obstructive mechanical valve thrombosis: the multicenter HATTUSHA study, J Am Coll Cardiol, 79, 977, 10.1016/j.jacc.2021.12.027 · doi:10.1016/j.jacc.2021.12.027
  141. Sadeghipour, 2022, Fast vs. ultraslow thrombolytic infusion regimens in patients with obstructive mechanical prosthetic valve thrombosis: a pilot randomized clinical trial, Eur Heart J Cardiovasc Pharmacother, 8, 668, 10.1093/ehjcvp/pvab083 · doi:10.1093/ehjcvp/pvab083
  142. Bemurat, 1999, Management of nonobstructive thrombosis of prosthetic mitral valve in asymptomatic patients in the early postoperative period: a study in 20 patients, Echocardiography, 16, 339, 10.1111/j.1540-8175.1999.tb00823.x · doi:10.1111/j.1540-8175.1999.tb00823.x
  143. Mutuberría-Urdaniz, 2015, Non-obstructive prosthetic heart valve thrombosis (NOPVT): really a benign entity?, Int J Cardiol, 197, 16, 10.1016/j.ijcard.2015.06.021 · doi:10.1016/j.ijcard.2015.06.021
  144. Whisenant, 2020, One-year outcomes of mitral valve-in-valve using the SAPIEN 3 transcatheter heart valve, JAMA Cardiol, 5, 1245, 10.1001/jamacardio.2020.2974 · doi:10.1001/jamacardio.2020.2974
  145. Suchá, 2014, Multidetector-row computed tomography allows accurate measurement of mechanical prosthetic heart valve leaflet closing angles compared with fluoroscopy, J Comput Assist Tomogr, 38, 451, 10.1097/RCT.0b013e3182ab5f15 · doi:10.1097/rct.0b013e3182ab5f15
  146. Roudaut, 2003, Surgery for prosthetic valve obstruction. A single center study of 136 patients, Eur J Cardiothorac Surg, 24, 868, 10.1016/s1010-7940(03)00568-2 · doi:10.1016/s1010-7940(03)00568-2
  147. Nishanth, 2020, Fibrinolysis in left-sided mechanical prosthetic valve thrombosis with high INR, Eur Heart J Acute Cardiovasc Care, 9, S58, 10.1177/2048872619846329 · DOI
  148. Separham, 2015, Prosthetic valve thrombosis, J Card Surg, 30, 246, 10.1111/jocs.12510 · doi:10.1111/jocs.12510
  149. Luis, 2020, Impact of aortic valve replacement for severe aortic stenosis on perioperative outcomes following major noncardiac surgery, Mayo Clin Proc, 95, 727, 10.1016/j.mayocp.2019.10.038 · doi:10.1016/j.mayocp.2019.10.038
  150. El Sabbagh, 2021, Predictors of left ventricular outflow tract obstruction after transcatheter mitral valve replacement in severe mitral annular calcification: an analysis of the Transcatheter Mitral Valve Replacement in Mitral Annular Calcification Global Registry, Circ Cardiovasc Interv, 14, e010854, 10.1161/CIRCINTERVENTIONS.121.010854 · doi:10.1161/circinterventions.121.010854

Cited by

See all 1,072

Metadata

Authors
Praz, F., Borger, M. A., Lanz, J., Marin-Cuartas, M., Abreu, A., Adamo, M., Ajmone Marsan, N., Barili, F., Bonaros, N., Cosyns, B., De Paulis, R., Gamra, H., Jahangiri, M., Jeppsson, A., Klautz, R. J. M., Mores, B., Pérez-David, E., Pöss, J., Prendergast, B. D., Rocca, B., Rossello, X., Suzuki, M., Thiele, H., Tribouilloy, C. M., Wojakowski, W., ESC/EACTS Scientific Document Group, Vahanian, A., Mestres, C.-A., Abid, L., Aktaa, S., Akowuah, E. F., Arbelo, E., Asselbergs, F. W., Barbato, E., Boriani, G., Brida, M., Buccheri, S., Byrne, R. A., Chioncel, O., Conradi, L., De Bonis, M., Delgado, V., Franzone, A., Haugaa, K. H., Heidecker, B., Ibanez, B., Iung, B., James, S., Køber, L., Koskinas, K. C., Landmesser, U., Lip, G. Y. H., McEvoy, J. W., Meltzer, G., Messika-Zeitoun, D., Mihaylova, B., Mindham, R., Moelgaard, I., Nielsen, J. C., Owens, G., Pasquet, A. A., Pilgrim, T., Prescott, E., Quintana, E., Rudolph, V., Sadaba, R., Sannino, A., Tanner, F. C., Urena, M., Vaartjes, I., Vrints, C., Wahba, A., Walther, T., Witkowski, A., Zeppenfeld, K., Shuka, N., Kichou, B., Chilingaryan, A. L., Bartko, P. E., Samadov, F., Van de Heyning, C. M., Kusljugic, Z., Kinova, E., Bulum, J., Eftychiou, C., Linkova, H., Fosbøl, E., Bahaa, H., Truusalu, J., Piuhola, J., Donal, E., Petriashvili, S., Rudolph, T. K., Drakopoulou, M., Kertész, A., Guðmundsson, H., Cole, B., Carasso, S., Navazio, A., Sugralimova, M., Bajraktari, G., Kerimkulova, A., Elgdhafi, E. O., Glaveckaite, S., Lebrun, F., Demarco, D. C., Lisii, D. M., Streukens, S., Antova, E., Dalen, H., Kukulski, T., Gavina, C., Popescu, B. A., Bini, R., Ivanov, I., Hudec, M., Bunc, M., Bermejo, T. J., Meurling, C. J. C., Jeger, R., Abid, L., Degertekin, M. M., Nesukay, E. G., Garbi, M., Mullabayeva, G., Grabenwoeger, M., Eynden, F. V., Vojacek, J., Vincentelli, A., Falk, V., Dedeilias, P., Parolari, A., Braun, J., Nikolic, A., Ellensen, V. S., Sousa-Uva, M., Micovic, S., Legarra, J. J., Ferrari, E., & Moorjani, N.
Venue
European Heart Journal
Publisher
Oxford University Press (OUP)
Published
2025-08-29
Volume
46
Issue
44
Pages
4635-4736
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
DOI
10.1093/eurheartj/ehaf194
OpenAlex
W4413812708
Cited by
1,072
References
862
FWCI
682.63
Type
journal article
Language
en
Open access
bronze
Licence
academic.oup.com/pages/standard-publication-reuse-rights (vor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: 2025 ESC/EACTS Guidelines for the management of valvular heart disease. https://app.cochat.ai/papers/10.1093/eurheartj/ehaf194
The paper
Praz, F., Borger, M. A., Lanz, J., Marin-Cuartas, M., Abreu, A., Adamo, M., Ajmone Marsan, N., Barili, F., Bonaros, N., Cosyns, B., De Paulis, R., Gamra, H., Jahangiri, M., Jeppsson, A., Klautz, R. J. M., Mores, B., Pérez-David, E., Pöss, J., Prendergast, B. D., . . . Moorjani, N. (2025). 2025 ESC/EACTS Guidelines for the management of valvular heart disease. European Heart Journal. https://doi.org/10.1093/eurheartj/ehaf194

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.